ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
3
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,224
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing.
Author(s):
Iris R Hartley
1
,
Michael T Collins
1
Publication date
(Electronic):
Dec 2021
Journal:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Publisher:
Wiley
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
2022 Research and Innovation Open Distance and eLearning (ODeL) Virtual Conference
Author and article information
Journal
Journal ID (iso-abbrev):
J Bone Miner Res
Title:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Publisher:
Wiley
ISSN (Electronic):
1523-4681
ISSN (Print):
0884-0431
Publication date (Electronic):
Dec 2021
Volume
: 36
Issue
: 12
Affiliations
[
1
]
National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Article
DOI:
10.1002/jbmr.4318
PubMed ID:
33950530
SO-VID:
4a0de81e-a4af-483c-ac07-e9599328410a
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,224
Favorable Effects of Burosumab on Fibroblast Growth Factor 23-Related Osteomalacia: A Case Report
Authors:
Yuki Oe
,
Hiraku Kameda
,
Hiroshi Nomoto
…
A phase 3 randomized, double-blind, placebo-controlled study investigating the efficacy and safety of burosumab, an anti-FGF23 antibody, in adult X-linked hypophosphatemia [abstract no. OC3.1]
Authors:
P Kamenicky
,
R Lachmann
,
TO Carpenter
The effect of burosumab (KRN23), a fully human anti-FGF23 monoclonal antibody, on osteomalacia in adults with X-linked hypophosphatemia (XLH)
Authors:
Insogna
See all similar
Cited by
3
Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
Authors:
Yuichi Takashi
,
Kyoko Toyokawa
,
Naoki Oda
…
Preoperative evaluation and orthopedic surgical strategies for tumor-induced osteomalacia
Authors:
Shuzhong Liu
,
Xi Zhou
,
Yong Liu
…
Tumor-Induced Osteomalacia due to Sarcomatoid Non–Small Cell Lung Carcinoma Confounded by Drug-Induced Fanconi Syndrome
Authors:
Bassam AlHamer
,
Ajit Singh
,
Carmen Patrascu
…
See all cited by